Uso de Hemospray® en sangrado post-escleroterapia
Author(s) -
Beatriz González Ortíz,
Dora María Tapia Monge,
Alicia Reyes Cerecedo,
Oscar Hernández Mondragón
Publication year - 2016
Publication title -
boletín médico del hospital infantil de méxico
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.165
H-Index - 12
eISSN - 1665-1146
pISSN - 0539-6115
DOI - 10.1016/j.bmhimx.2016.06.005
Subject(s) - psychology
Hemospray® is a new device for endoscopic hemostasis used for non-variceal gastrointestinal bleeding. It enables hemostasis and platelet activation by increasing the concentration of clotting factors and forming a mechanical barrier on the wall of a bleeding vessel creating a mechanical plug at the site of bleeding. Within the main indications for use are: injuries with difficult endoscopic access, massive gastrointestinal bleeding, multiple bleeding sites, modification of the anatomy by previous endoscopic therapy, presence of coagulopathy, difficulty in having direct visualization or when it is impossible to have contact with the bleeding lesion. However, its use in children has not been approved yet by the FDA. There is a case report of an 11-month-old patient successfully treated with Hemospray® for non-variceal gastrointestinal bleeding.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom